Диссертация (1154746), страница 19
Текст из файла (страница 19)
Isolation and characterization of thesubunits of human plasma carboxypeptidase N (kininase I) // Proc. Natl Acad. Sci.USA. – 1982, - V 79. – P. 4618-4622.213. Li B., Fu J., Chen P., Zhuang W. Impairment in immunomodulatoryfunction of mesenchymal stem cells from multiple myeloma patients // Arch. Med.Res.
– 2010, - V 41, - N 8. – P. 623-633.214. Linares C.I., Ferrín G., Aguilar-Melero P., González-Rubio S., et al.Sensitivity to anti-Fas is independent of increased cathepsin D activity and121adrenodoxin reductase expression occurring in NOS-3 overexpressing HepG2 cells// Biochim Biophys Acta. 2015. N 1853(5). p. 1182-1194.215.
Liu A., Shao C., Jin G., Liu R., Hao J., Shao Z., Liu Q., Hu X.Downregulation of CPE regulates cell proliferation and chemosensitivity inpancreatic cancer // Tumour Biol. 2014. N 35(12). p. 12459-12465.216. Loh Y.P., Birch N.P., Castro M.G. Pro-opiomelanocortin and provasopressin converting enzyme in pituitary secretory vesicles // Biochimie. – 1988.– 70, N 1. – P. 11-16.217. Lucini C., Costagliola C., Borzacchiello G., Castaldo L.
Neurotrophin 3 andits receptor TrkC immunoreactivity in glucagon cells of buffalo pancreas // Nat.Neurosci. – 2003, - V 6, - N 3. – P. 221-222.218. Lysenko L.A., Kantserova N.P., Krupnova M.Y., Veselov A.E., NemovaN.N. Intracellular Protein Degradation in Growth of Atlantic Salmon, Salmo salarL // Bioorg Khim. 2015. N 41 (6). p. 717-724.219. Ma N., Wu S.S., Ma Y.X., Wang X., Zeng J., Tong G., Huang Y., Wang S.Nerve growth factor receptor-mediated gene transfer // Mol Ther. – 2004, - V 9, N 2. – P. 270-281.220.
Mackay K.B., Loddick S.A., Naeve G.S., Vana A.M., Verge G.M., FosterA.C. Neuroprotective effects of insulin-like growth factor-binding protein ligandinhibitors in vitro and in vivo // J Cereb. Blood Flow Metab. – 2003, - V 23, - N10. – P. 1160-1167.221. Mandava S., Makowski L., Devarapalli S., Uzubell J., Rodi D.J.
RELIC--abioinformatics server for combinatorial peptide analysis and identification ofprotein-ligand interaction sites // Proteomics. – 2004, – N 4. – P. 1439–1460222. Manser, E., Fernandez, D., Loo,L., Goh, P.Y., Monfries, C., Hall, C. andLim,L. Human carboxypeptidase E: isolation and characterisaton of the cDNA,sequence conservation, expression and processing in vitro // Biochem. J. – 1990, –V 267. – P. 517-525.122223. Margaryan N.V., Kirschmann D.A., Lipavsky A., Bailey C.M., HendrixM.J., Khalkhali-Ellis Z. New insights into cathepsin D in mammary tissuedevelopment and remodeling // Cancer Biol Ther.
2010, N 1. 10 (5). p. 457-466.224. Marks N., Berg M., Kastin A., Coy D. Evidence for conversion of N-TyrMIF-1 into MIF-1 by a specific brain aminopeptidase // Neurochem. Intern. –1984. – 6. – P. 347-353.225. Martin P., Massol J., Puech A.J. Captopril as an antidepressant? Effects onthe learned helplessness paradigm in rats // Biol. Psyhiatry. – 1990. – 27, № 9. – P.968-974.226. Melzer I.M., Fernández S.B., Bösser S., Lohrig K., et.
al. The Apaf-1binding protein Aven is cleaved by Cathepsin D to unleash its anti-apoptoticpotential // Cell Death Differ. 2012. N 19(9). p. 1435-1445.227. Mentlein R., Dahms P. Endopeptidase-24.16 and endopeptidase-24.15 areresponsible for the degradation of somatostatin, neurotensin, and otherneuropeptides by cultivated rat cortical astrocytes // J.
Neurochem. – 1994. – 62, 1.– P. 27-36.228. Merighi A. Targeting the glial-derived neurotrophic factor and relatedmolecules for controlling normal and pathologic pain // Expert Opin Ther Targets.2015. N 20 (2). p. 193-208.229. Merighi A., Carmignoto G., Gobbo S., Lossi L., Salio C., Vergnano A.M.,Zonta M. Neurotrophins in spinal cord nociceptive pathways // Prog Brain Res. –2004, - V 146. – P. 291-321.230. MitraA.,SongL.X.,FrickerL.D.TheC-terminalregionofcarboxypeptidase E is involved in membrane-binding and intracellular routing inAtt-20 cells // J. Biol.
Chem. – 1994. – V. 269, № 31. – P. 19876-19881.231. Monje L., Varayoud J., Muñoz-de-Toro M., Luque E.H., Ramos J.G.Exposure of neonatal female rats to bisphenol A disrupts hypothalamic LHRH premRNA processing and estrogen receptor alpha expression in nuclei controllingestrous cyclicity // Reprod. Toxicol. – 2010, - V 30, - N 4. – P. 625-634.123232. Mungunsukh O., Marquez A.P., Lee Y.H., Thiel G., Day R.M.Characterization of the bovine angiotensin converting enzyme promoter: essentialroles of Egr-1, ATF-2 and Ets-1 in the regulation by phorbol ester // Gene. – 2008,- V 421, - N 1-2. – P. 81-88.233.
Nadji M., Fresno M., Nassiri M., Conner G., Herrero A., Morales A.R.,Cathepsin D in host stromal cells, but not in tumor cells, is associated withaggressive behavior in node-negative breast cancer // Hum. Pathol. 1996, N 27. p.890–895.234. Nagano K. Alteration of cathepsin-D expression in atrophied muscles andapoptotic myofibers by hindlimb unloading in a low-temperature environment // JPhys Ther Sci. 2015. N 27 (11). p. 3585-3591.235. Nalamachu S.R., Song L.X., Fricker L.D. Regulation of carboxypeptidase E- effect of Ca2+ on enzyme-activity and stability // J.
Biol. Chem. – 1994. – V. 269,№ 15. – P. 11192-11195.236. Nanba D., Toki F., Higashiyama S. Roles of charged amino acid residues inthe cytoplasmic domain of proHB-EGF // Biochem. Biophys. Res. Commun. –2004, - V 320, - N 2. – P. 376-282.237. Nassenstein C., Braun A., Erpenbeck V.J., Lommatzsch M., Schmidt S.,Krug N. The neurotrophins nerve growth factor, brain-derived neurotrophic factor,neurotrophin-3, and neurotrophin-4 are survival and activation factors foreosinophils in patients with allergic bronchial asthma // J Exp.
Med. – 2003, - V198, - N 3. – P. 455-467.238. Nath R., Davis M., Probert A.W., Kupina N.C., Ren X.D., Schielke G.P.,Wang K.K.W. Processing of Cdk5 activator P35 to Its truncated form (P25) bycalpain in acutely injured neuronal cells // Biochem. Biophys. Res. Commun. –2000. – 274, N 1. – P. 16-21.239. Nishishita T., Lin P.C. Angiopoietin I., PDGF-B, and TGF-beta generegulation in endothelial cell and smooth muscle cell interaction // J Cell Biochem.– 2004. – V 91, - N 3. – P. 584-593.124240. Nomiyama H., Osada N., Yoshie O. A family tree of vertebrate chemokinereceptors for a unified nomenclature // Dev Comp Immunol.
– 2011, - N 2. – P. 1120.241. Norman J.A., Autry W.L., Barbaz B.S. Angiotensin-converting enzymeinhibitors potentiate the analgesic activity of [Met]-enkephalin-Arg6-Phe7 byinhibiting its degradation in mouse brain // Mol. Pharmacol. – 1985. – 28, N 6. – P.521-526.242. O’Cuinn G. Peptide methabolism in cytoplasm of brain cells // Biochem.Soc. Trans. – 1998. – 6, N 3. – P. 279-292.243.
O’Donoghue A.E., Poller D.N., Bell J.A., Galea M.H., Elston C.W., BlameyR.W., et al. Cathepsin D in primary breast carcinoma: adverse prognosis isassociated with expression of cathepsin D in stromal cells // Breast Cancer Res.Treat. 1995. N 33. p. 137–145.244. Ohri S.S., Vashishta A., Vetvickova J., Fusek M., Vetvicka V. ProcathepsinD expression correlates with invasive and metastatic phenotype of MDA-MB-231derived cell lines // Int J Biol Macromol. 2007. N 1. 41 (2).
p. 204-209.245. Oliveira C.S., Pereira H., Alves S., Castro L., Baltazar F., et al. Cathepsin Dprotects colorectal cancer cells from acetate-induced apoptosis through autophagyindependent degradation of damaged mitochondria // Cell Death Dis. 2015. N 18.V 6.
p. 1788.246. Parkinson D. Two soluble forms of bovine carboxypeptidase H havedifferent NH2-terminal sequences // J. Biol. Chem. – 1990. – V. 265, № 28. – P.17101-17105.247. Perloff M.D., Kream R.M., Beinfeld M.C. Reduced levels of substance P inthe brains of Cpe(fat)/Cpe(fat) mice // Peptides. – 1998. – 19, N 6.
– P. 1115-1117.248. Piccinini M., Tazartes O., Mostert M., Musso A., Demarchi M., RinaudoM.T. Structural and functional characterization of 20S and 26S proteasomes frombovine brain // Mol. Brain Res. – 2000. – 76, N 1. – P. 103-114.249. Pisano M, Palomba A, Tanca A, Pagnozzi D, Uzzau S, Addis MF, DettoriMA, Fabbri D, Palmieri G, Rozzo C. Protein expression changes induced in a125malignant melanoma cell line by the curcumin analogue compound D6 // BMCCancer. 2016 18; 16 (1), р. 317250. Plaza A., Garcia-Esteve L., Ascaso C., Navarro P., Gelabert E., Halperin I.,Valdés M., Martín-Santos R. Childhood sexual abuse and hypothalamus-pituitarythyroid axis in postpartum major depression // J Affect.
Disord. – 2010, - V 122, N 1-2. – P. 159-163.251. Plummer T.H., Erdös E.G. Human plasma carboxypeptidase N // MethodsEnzymol. – 1981, - V 80. – P. 442-449.252. Pranjol M.Z., Gutowski N., Hannemann M., Whatmore J. The Potential Roleof the Proteases Cathepsin D and Cathepsin L in the Progression and Metastasis ofEpithelial Ovarian Cancer // Biomolecules.
2015. N 20;5(4). p. 3260-3279.253. Pritchard L.E., White A. Neuropeptide Processing and Its Impact onMelanocortin Pathways // Endocrinology. 2008. 148, N 9. P. 4201-4207.254. Pshezhetsky A.V., Potier M. Direct affinity purification and supramolecularorganization of human lysosomal cathepsin A // Arch. Biochem.
Biophys. – 1994.– 313, N 1. – P. 64-70.255. Rochefort H. Cathepsin D in breast cancer: a tissue marker associated withmetastasis // Eur. J. Cancer. 1992. N 28A. p. 1780–1783.256. Roger P., Montcourrier P., Maudelonde T., Brouillet J.P., Page`s A.,Laffargue F., et al. Cathepsin D immunostaining in paraffin-embedded breastcancer cells and macrophages. Correlation with cytosolic assay // Human Path.1994. N 25. p. 863–871.257. Roth S.M., Metter E.J., Lee M.R., Hurley B.F., Ferrell R.E. C174Tpolymorphism in the CNTF receptor gene is associated with fat-free mass in menand women // J Appl.
Physiol. – 2003, - V 95, - N 4. – P. 1425-1430.258. Rouille Y., Chauvet J., Acher R. Partial conversion of vasopressinyl-GlyLys-Arg into pharmacologically active vasopressin through secretory granulecarboxypeptidase E and alpha-amidating processing enzymes // Biochem. Int. –1992. – 26, N 4. – P.739-746.126259. Saad W.A., Camargo L.A., Renzi A., Junior L.A., Rodrigues A.J., SaadW.A.
Alterations in the water intake caused by central inhibition of angiotensinconverting enzyme in the rat // Neurosci. Lett. – 1992. – 134, N 2. – P. 212-214.260. Saftig P., Hetman M., Schmahl W., Weber K., Heine L., Mossmann H., etal., Mice deficient for the lysosomal proteinase cathepsin D exhibit progressiveatrophy of the intestinal mucosa and profound destruction of lymphoid cells // Eur.Mol. Bio. J. 1999, 14. p.
3599–3608.261. Sapi E. The role of CSF-1 in normal physiology of mammary gland andbreast cancer: an update // Exp. Biol. Med. (Maywood). – 2004, - V 229, - N 1. –P. 1-11.262. Schnebli H.P., Phillipps M.A., Barclay R.K. Isolation and characterization ofan enkephalin-degrading aminopeptidase from rat brain // Biochim. Biophys. Acta.– 1979. – 569, N 1.